ARRAY BIOPHARMA INC
Customers
5
0 disclosed
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Sep 30, 2015
10-Q filed 2015-11-06
Customers 5
Companies ARRAY BIOPHARMA INC discloses as major customers, as a share of ARRAY BIOPHARMA INC revenue. 0 active, 5 lapsed.
| Company | % of ARRAY BIOPHARMA INC revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| NVS NOVARTIS AG |
65% | $10.5M | 3M 2015-09-30 | Lapsed Last seen 2015-09-30 |
10-Q 2015-11-06 | |
Novartis 65.0 % — % | ||||||
| Oncothyreon Inc. Non-SEC Oncothyreon Inc. |
42.3% | $22.0M | FY 2015-06-30 | +34.1pp | Lapsed Last seen 2015-06-30 |
10-K 2015-08-21 |
Oncothyreon Inc. 42.3 % 8.2 % 14.4 % Oncothyreon Inc. 4.1 % 10.8 % 55.2 % 7.4 % Oncothyreon Inc. 76.3 % 8.0 % 65.4 % 6.6 % | ||||||
| Loxo Oncology, Inc. Loxo Oncology, Inc. |
37.8% | $2.3M | 3M 2014-09-30 | −1.6pp | Lapsed Last seen 2014-09-30 |
10-Q 2014-11-05 |
Loxo Oncology, Inc. 37.8 % 39.4 % | ||||||
| Novartis International Pharmaceutical Ltd. Non-SEC Novartis International Pharmaceutical Ltd. |
28.6% | $12.0M | FY 2014-06-30 | +3.1pp | Lapsed Last seen 2014-06-30 |
10-K 2014-08-15 |
Novartis International Pharmaceutical Ltd. 28.6 % 25.5 % 16.2 % | ||||||
| AZN ASTRAZENECA PLC |
0.2% | $15.5K | 3M 2014-03-31 | −35.7pp | Lapsed Last seen 2014-03-31 |
10-Q 2014-05-09 |
AstraZeneca AB 0.2 % 0.2 % 14.1 % 0.4 % AstraZeneca AB 35.9 % — % 17.9 % — % | ||||||
Alerts are coming
Get an email when ARRAY BIOPHARMA INC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.